Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stereoselectivity in pharmacokinetics: a general theory.

R H Levy1, A V Boddy

  • 1Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle 98195.

Pharmaceutical Research
|May 1, 1991
PubMed
Summary

Pharmacokinetic stereoselectivity, the difference in how the body processes drug enantiomers, varies with the complexity of biological organization. Higher organization levels show greater parameter hybridity, impacting drug distribution and elimination.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The amplitude and origin of sea-level variability during the Pliocene epoch.

Nature·2019
Same author

Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.

British journal of clinical pharmacology·2018
Same author

Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study).

Pediatric blood & cancer·2017
Same author

A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia.

Pediatric blood & cancer·2016
Same author

RMP-7 : Potential as an Adjuvant to the Drug Treatment of Brain Tumours.

CNS drugs·2016
Same author

The multi-millennial Antarctic commitment to future sea-level rise.

Nature·2015

Area of Science:

  • Pharmacology
  • Biochemistry
  • Drug Metabolism

Background:

  • Stereoselectivity in pharmacokinetics refers to measurable differences in pharmacokinetic parameters between enantiomers of a chiral drug.
  • Pharmacokinetic parameters can be organized by biological levels: molecular, organ, and whole body.
  • The hybrid character of pharmacokinetic parameters increases with the level of biological organization they represent.

Purpose of the Study:

  • To propose a classification system for pharmacokinetic parameters based on their level of biological organization and hybrid character.
  • To investigate the relationship between the hybrid character of pharmacokinetic parameters and the stereoselectivity of drug enantiomers.
  • To examine how stereoselectivity is influenced by different levels of organization in drug distribution and elimination.

Related Experiment Videos

Main Methods:

  • Classifying pharmacokinetic parameters according to three levels of organization: molecular, organ, and whole body.
  • Defining pharmacokinetic parameters by their 'hybrid character,' reflecting the integration of stereoselectivity from lower levels.
  • Examining the hypothesis that kinetic differences between enantiomers are inversely correlated with the degree of hybrid character using data from warfarin, verapamil, mephenytoin, and propranolol.

Main Results:

  • Pharmacokinetic parameters exhibit increasing hybrid character with higher levels of biological organization (molecular, organ, whole body).
  • Stereoselectivity at lower organizational levels can be amplified or dampened in parameters at higher levels.
  • The study examined four drugs, finding an inverse correlation between kinetic differences of enantiomers and the hybrid character of pharmacokinetic parameters.

Conclusions:

  • Classifying pharmacokinetic parameters by organizational level and hybrid nature provides a framework for understanding stereoselectivity.
  • This classification helps explain variations in stereoselectivity observed in drug distribution and elimination.
  • The findings offer insights into predicting and managing enantiomer-specific drug behavior in vivo.